生物标志物
本发明提供预测使用IAP拮抗剂有效治疗癌症的生物标志物。鉴定癌症患者中的一种或多种经鉴定的生物标志物能够确定是否使用IAP拮抗剂可能成功地治疗该患者的癌症。因此本发明大体上涉及用于IAP拮抗剂疗法的伴随诊断。特别地,所述生物标志物包括IL‑2Rα、IL‑6r、CRP、EPO、CD27、CD40、TN‑C、IL‑18、PLGF、TNFrI和MCP‑4。
APPLICANTS
Browse source applicant names and unchanged name fields from imported patent records.
These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.
This name was extracted from a distinct applicant node in the source XML.
1 indexed patent records
Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.
Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.
Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.
Search patents with this applicant condition